considering the results are due in a couple of days, the directors are not allowed to trade I think buying at this level (around book value) is a reasonable investment for a company positioned into this sector.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025